APA (7th ed.) Citation

CS, R., W, L., BJ, P., CS, V., CJ, S., N, B., & M, M. (2025). The tetravalent, bispecific properties of FS118, an anti-LAG-3/PD-L1 antibody, mediate LAG-3 shedding from CD4 + and CD8 + tumor-infiltrating lymphocytes. Anti-cancer drugs, 36(6), 447. https://doi.org/10.1097/CAD.0000000000001705

Chicago Style (17th ed.) Citation

CS, Reader, Liao W, Potter-Landua BJ, Veyssier CS, Seal CJ, Brewis N, and Morrow M. "The Tetravalent, Bispecific Properties of FS118, an Anti-LAG-3/PD-L1 Antibody, Mediate LAG-3 Shedding from CD4 + and CD8 + Tumor-infiltrating Lymphocytes." Anti-cancer Drugs 36, no. 6 (2025): 447. https://doi.org/10.1097/CAD.0000000000001705.

MLA (9th ed.) Citation

CS, Reader, et al. "The Tetravalent, Bispecific Properties of FS118, an Anti-LAG-3/PD-L1 Antibody, Mediate LAG-3 Shedding from CD4 + and CD8 + Tumor-infiltrating Lymphocytes." Anti-cancer Drugs, vol. 36, no. 6, 2025, p. 447, https://doi.org/10.1097/CAD.0000000000001705.